Non-Invasive Prenatal Testing Market: was valued at US$ 1.77 Bn in 2019 and is expected to reach 5.2 Bn by 2027, at a CAGR of 16.81 % during a forecast period.
Non-Invasive Prenatal Testing Market Overview:
Non-invasive prenatal testing (NIPT) is a new genetic broadcast technique based on the analysis of cell-free incurable DNA in the maternal plasma. The market for non-invasive prenatal testing is growing knowingly over global, due to rise in occurrences of chromosomal aneuploidies among fetus, growing demand for initial, non-invasive screening procedures, and increase in progressive maternal age (earlier 23 to 26 years has increased to 30 years) which led to increase the growth of market share during the forecast period.
The Non-Invasive Prenatal Testing Market Report 2020-2027 (Forecast Period) includes an analysis of market growth factors, future analysis, country-level, and regional-level analysis, market distribution, and competitive landscape analysis of major key competitors. Within the analysis report, each phase of the world global market is completely studied. The regional study of the global market will help you in gaining an understanding of the developments of the various geographic markets in recent years and moving ahead. The analysis also includes a wide-ranging synopsis of the key factors of the global market, like market influence and market result factors, drivers, threats, constraints, trends, restraints, and prospects. alternative methods of analysis, like qualitative and quantitative, also are used within the analysis study.
Maximize Market Research team analysis provides a unique and in-depth report that helps you to perform detailed research on the global Non-Invasive Prenatal Testing market and make decisions on the future growth factors of the market. The market report provides an overview of the development of the Non-Invasive Prenatal Testing market throughout the forecasted period.
Request for free sample: https://www.maximizemarketresearch.com/request-sample/32130
The Non-Invasive Prenatal Testing market report thoroughly covers insights of key competitors in terms of market, applications, and geographies that will help you in recognizing the competition both domestic as well as globally. The research mentions available micro-market investment options for investors and a full synopsis of the competitive landscape and significant products offered by industries.
The report also includes statistical data that consists of tables and charts which will further help you in business representation. Maximize Market Research also studies the current as well as new trends with the estimations of the market size throughout the forecasted period. Many competitors are also identified in various regions. The report provides PESTEL and Portal analysis too, which helps the clients to calculate every factor of the market.
Non-Invasive Prenatal Testing Market Segmentation:
North America is expected to increase the global non-invasive prenatal testing market, owing to the growing average maternal age, increasing healthcare expenditure, growing demand for the initial and non-invasive procedures, and increasing prevalence of chromosome syndromes in the region. Among the North American countries, the U.S. leads to the NIPT market in North America and it is expected to hold a market share of over 80% by 2019. It is also anticipated to be the fastest-growing market for NIPT in the region during the forecast period.
Non-Invasive Prenatal Testing Market Key Players:
• Berry Genetics
• BGI
• Laboratory Corporation of America Holdings
• Agilent Technologies, Inc.
• Illumina, Inc
• Hoffmann-La Roche Ltd
• NATERA, INC.
• PerkinElmer Inc
• Eurofins LifeCodexx AG
• IGENOMIX.
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Yourgene Health
• Genesis Genetics
• Centogene N.V.
• MedGenome Labs Ltd.
• Myriad Women’s Health, Inc.
• Progenity, Inc.
• Qiagen
• Quest Diagnostics, Inc.
Get more Report Details: https://www.maximizemarketresearch.com/market-report/global-non-invasive-prenatal-testing-market/32130/
Non-Invasive Prenatal Testing Market Regional Analysis:
Based on the regions the market is studied across
- Asia-Pacific (Vietnam, Malaysia, Korea, China, Philippines, Thailand, Indonesia, and India, Japan, Australia, ).
- Africa and the Middle East (Egypt and GCC Countries.).
- North America (Canada, the United States, and Mexico.).
- South America (Brazil etc.).
- Europe (France, Italy, Germany, Russia, UK, Turkey, etc.).
IMPACT Of COVID-19 On The Non-Invasive Prenatal Testing Market:
COVID-19 has impacted the world with its fast-spreading effects all over the world. It has impacted every industry and business except for the medical and health care industry which is working 24/7 to stop the spread of the COVID-19 virus, they are working hard to save the lives of people affected by this virus. As mentioned many industries are suffering in this COVID-19 times, our market is also one of them. Our team here at Maximize Market Research has worked hard to provide solutions to these issues that will help your business.
If You Have Any Questions About This Report? Please Contact Us On the link mentioned below:
About Us:
Maximize Market Research provides B2B and B2C research on more than 12000 high growth emerging opportunities technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics Communications, Internet of Things, Food and Beverages, Aerospace and Defense, and other manufacturing sectors.
Contact Us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2,
Pune Bangalore Highway,
Narhe, Pune, Maharashtra 411041, India.
Email: [email protected]
Phone No.: +91 20 6630 3320
Website: www.maximizemarketresearch.com
